Neural Functions Play Different Roles in Triple Negative Breast Cancer (TNBC) and non-TNBC

被引:16
|
作者
Tan, Renbo [1 ,2 ]
Li, Haoyang [2 ,3 ]
Huang, Zhenyu [2 ]
Zhou, Yi [5 ,6 ]
Tao, Mingxin [2 ]
Gao, Xin [4 ]
Xu, Ying [2 ,3 ,5 ,6 ]
机构
[1] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China
[2] Jilin Univ, China Japan Union Hosp, Canc Syst Biol Ctr, Changchun 130033, Peoples R China
[3] Jilin Univ, Coll Comp Sci & Technol, Changchun 130012, Peoples R China
[4] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal 23955, Saudi Arabia
[5] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA
[6] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA
关键词
PERINEURAL INVASION; PANCREATIC-CANCER; PROSTATE-CANCER; SCHWANN-CELLS; SYSTEM; REGENERATION; INNERVATION; MECHANISMS; NEUROGENESIS; INFLAMMATION;
D O I
10.1038/s41598-020-60030-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Triple negative breast cancer (TNBC) represents the most malignant subtype of breast cancer, and yet our understanding about its unique biology remains elusive. We have conducted a comparative computational analysis of transcriptomic data of TNBC and non-TNBC (NTNBC) tissue samples from the TCGA database, focused on genes involved in neural functions. Our main discoveries are: (1) while both subtypes involve neural functions, TNBC has substantially more up-regulated neural genes than NTNBC, suggesting that TNBC is more complex than NTNBC; (2) non-neural functions related to cell-microenvironment interactions and intracellular damage processing are key inducers of the neural genes in both TNBC and NTNBC, but the inducer-responder relationships are different in the two cancer subtypes; (3) key neural functions such as neural crest formation are predicted to enhance adaptive immunity in TNBC while glia development, along with a few other neural functions, induce both innate and adaptive immunity in NTNBC. These results reveal key differences in the biology between the two cancer subtypes, particularly in terms of the roles that neural functions play. Our findings may open new doors for further investigation of the distinct biology of TNBC vs. NTNBC.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Neoadjuvant cisplatin and bevacizumab in triple negative breast cancer (TNBC): Safety and efficacy
    Ryan, P. D.
    Tung, N. M.
    Isakoff, S. J.
    Golshan, M.
    Richardson, A.
    Corben, A. D.
    Smith, B. L.
    Gelman, R.
    Winer, E. P.
    Garber, J. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] EGFR Overexpression in Triple Negative Breast Cancer (TNBC) and Its Association with the Prognosis
    Liu, W.
    Zhang, L.
    Ma, K.
    Han, B.
    Li, S.
    Xu, G.
    Fan, Z.
    Liu, N.
    Shi, A.
    CANCER RESEARCH, 2011, 71
  • [43] Quercetin obstructs Triple Negative Breast Cancer (TNBC) progression by targeting HuR
    Dev, Arundhathi J. R.
    Sheikh, Umar Mohammad
    Akanksha, Kashyap
    Chandra, Prasad Prakash
    PLANTA MEDICA, 2021, 87 (15) : 1249 - 1249
  • [44] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Cho, Eun Yoon
    Chang, Myung Hee
    Choi, Yoon La
    Lee, Jeong Eon
    Nam, Seok Jin
    Yang, Jung-Hyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Im, Young-Hyuck
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 753 - 761
  • [45] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Eun Yoon Cho
    Myung Hee Chang
    Yoon La Choi
    Jeong Eon Lee
    Seok Jin Nam
    Jung-Hyun Yang
    Yeon Hee Park
    Jin Seok Ahn
    Young-Hyuck Im
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 753 - 761
  • [46] Treatment of triple negative breast cancer (TNBC): current options and future perspectives
    De Laurentiis, M.
    Cianniello, D.
    Caputo, R.
    Stanzione, B.
    Arpino, G.
    Cinieri, S.
    Lorusso, V.
    De Placido, S.
    CANCER TREATMENT REVIEWS, 2010, 36 : S80 - S86
  • [47] Triple Negative Breast (TNBC) Cancer in Hispanic Population: Clinicopathological and Recurrence Features
    Gomez, H. L.
    Velarde, R. G.
    Neciosup, S. P.
    Cruz, W. R.
    Mas, L. A.
    Suazo, J. F.
    Pinto, J. A.
    Vigil, C. E.
    Vallejos, C. S.
    CANCER RESEARCH, 2010, 70
  • [48] Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling
    Vishnubalaji, Radhakrishnan
    Alajez, Nehad M.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [49] Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
    Lee, Jieun
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [50] Discovery of a small molecule inhibitor for triple-negative breast cancer (TNBC)
    Saran, Uttara
    Chandrasekaran, Balaji
    Tyagi, Ashish
    Singh, Amandeep
    Ankem, Murali K.
    Sharma, Arun K.
    Damodaran, Chendil
    CANCER RESEARCH, 2022, 82 (12)